BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 30297743)

  • 21. PTK7 regulates Id1 expression in CD44-high glioma cells.
    Liu Q; Zhang C; Yuan J; Fu J; Wu M; Su J; Wang X; Yuan X; Jiang W
    Neuro Oncol; 2015 Apr; 17(4):505-15. PubMed ID: 25204555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigating bone morphogenetic protein (BMP) signaling in a newly established human cell line expressing BMP receptor type II.
    Kudo TA; Kanetaka H; Watanabe A; Okumoto A; Asano M; Zhang Y; Zhao F; Kano M; Shimizu Y; Tamura S; Hayashi H
    Tohoku J Exp Med; 2010 Oct; 222(2):121-9. PubMed ID: 20919447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dysregulation of the BMP-p38 MAPK signaling pathway in cells from patients with fibrodysplasia ossificans progressiva (FOP).
    Fiori JL; Billings PC; de la Peña LS; Kaplan FS; Shore EM
    J Bone Miner Res; 2006 Jun; 21(6):902-9. PubMed ID: 16753021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. V3 versican isoform alters the behavior of human melanoma cells by interfering with CD44/ErbB-dependent signaling.
    Hernández D; Miquel-Serra L; Docampo MJ; Marco-Ramell A; Cabrera J; Fabra A; Bassols A
    J Biol Chem; 2011 Jan; 286(2):1475-85. PubMed ID: 21078678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inverse expression of hyaluronidase 2 and hyaluronan synthases 1-3 is associated with reduced hyaluronan content in malignant cutaneous melanoma.
    Siiskonen H; Poukka M; Tyynelä-Korhonen K; Sironen R; Pasonen-Seppänen S
    BMC Cancer; 2013 Apr; 13():181. PubMed ID: 23560496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions between CD44 and hyaluronic acid: their role in tumor growth and metastasis.
    Sy MS; Liu D; Schiavone R; Ma J; Mori H; Guo Y
    Curr Top Microbiol Immunol; 1996; 213 ( Pt 3)():129-53. PubMed ID: 8815002
    [No Abstract]   [Full Text] [Related]  

  • 27. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension.
    Yang J; Davies RJ; Southwood M; Long L; Yang X; Sobolewski A; Upton PD; Trembath RC; Morrell NW
    Circ Res; 2008 May; 102(10):1212-21. PubMed ID: 18436795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age-related changes in pericellular hyaluronan organization leads to impaired dermal fibroblast to myofibroblast differentiation.
    Simpson RM; Meran S; Thomas D; Stephens P; Bowen T; Steadman R; Phillips A
    Am J Pathol; 2009 Nov; 175(5):1915-28. PubMed ID: 19808648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular weight specific impact of soluble and immobilized hyaluronan on CD44 expressing melanoma cells in 3D collagen matrices.
    Sapudom J; Ullm F; Martin S; Kalbitzer L; Naab J; Möller S; Schnabelrauch M; Anderegg U; Schmidt S; Pompe T
    Acta Biomater; 2017 Mar; 50():259-270. PubMed ID: 27965172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oligosaccharides of hyaluronan induce angiogenesis through distinct CD44 and RHAMM-mediated signalling pathways involving Cdc2 and gamma-adducin.
    Matou-Nasri S; Gaffney J; Kumar S; Slevin M
    Int J Oncol; 2009 Oct; 35(4):761-73. PubMed ID: 19724912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor-suppressive functions of 4-MU on breast cancer cells of different ER status: Regulation of hyaluronan/HAS2/CD44 and specific matrix effectors.
    Karalis TT; Heldin P; Vynios DH; Neill T; Buraschi S; Iozzo RV; Karamanos NK; Skandalis SS
    Matrix Biol; 2019 May; 78-79():118-138. PubMed ID: 29673760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PP2B and ERK1/2 regulate hyaluronan synthesis of HT168 and WM35 human melanoma cell lines.
    Katona É; Juhász T; Somogyi CS; Hajdú T; Szász C; Rácz K; Kókai E; Gergely P; Zákány R
    Int J Oncol; 2016 Mar; 48(3):983-97. PubMed ID: 26717964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyaluronan promotes the chondrocyte response to BMP-7.
    Andhare RA; Takahashi N; Knudson W; Knudson CB
    Osteoarthritis Cartilage; 2009 Jul; 17(7):906-16. PubMed ID: 19195913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.
    Bourguignon LYW; Earle C; Shiina M
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strong expression of ID1 protein is associated with decreased survival, increased expression of ephrin-A1/EPHA2, and reduced thrombospondin-1 in malignant melanoma.
    Straume O; Akslen LA
    Br J Cancer; 2005 Oct; 93(8):933-8. PubMed ID: 16189525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombin and NAD(P)H oxidase-mediated regulation of CD44 and BMP4-Id pathway in VSMC, restenosis, and atherosclerosis.
    Vendrov AE; Madamanchi NR; Hakim ZS; Rojas M; Runge MS
    Circ Res; 2006 May; 98(10):1254-63. PubMed ID: 16601225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyaluronan-CD44 interaction promotes HPV 16 E6 oncogene-mediated oropharyngeal cell carcinoma survival and chemoresistance.
    Bourguignon LYW; Earle C; Shiina M
    Matrix Biol; 2019 May; 78-79():180-200. PubMed ID: 30077625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor microenvironment modulates hyaluronan expression: the lactate effect.
    Rudrabhatla SR; Mahaffey CL; Mummert ME
    J Invest Dermatol; 2006 Jun; 126(6):1378-87. PubMed ID: 16543892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ΔNp63-mediated regulation of hyaluronic acid metabolism and signaling supports HNSCC tumorigenesis.
    Compagnone M; Gatti V; Presutti D; Ruberti G; Fierro C; Markert EK; Vousden KH; Zhou H; Mauriello A; Anemone L; Bongiorno-Borbone L; Melino G; Peschiaroli A
    Proc Natl Acad Sci U S A; 2017 Dec; 114(50):13254-13259. PubMed ID: 29162693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Id1 and Id3 co-expression correlates with clinical outcome in stage III-N2 non-small cell lung cancer patients treated with definitive chemoradiotherapy.
    Castañon E; Bosch-Barrera J; López I; Collado V; Moreno M; López-Picazo JM; Arbea L; Lozano MD; Calvo A; Gil-Bazo I
    J Transl Med; 2013 Jan; 11():13. PubMed ID: 23311395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.